We are live on
!
Find out more
FBC
Fairfield, Bush & Co Portfolio holdings
AUM
$180M
1-Year Est. Return
39.51%
This Fund
S&P 500
This Quarter
Est. Return
+9.18%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$368M
AUM Growth
+$17.6M
(+5%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-3.15%
Top 10 Holdings %
Top 10 Hldgs %
39.61%
Holding
168
New
6
Increased
49
Reduced
57
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.27M |
| 2 |
Walt Disney
DIS
|
+$3.04M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$1.73M |
| 4 |
Zimmer Biomet
ZBH
|
+$833K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$655K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$1.96M |
| 2 |
Apple
AAPL
|
+$1.91M |
| 3 |
Microsoft
MSFT
|
+$1.75M |
| 4 |
Autodesk
ADSK
|
+$1.66M |
| 5 |
Amazon
AMZN
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.51% |
| 2 | Healthcare | 17.25% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Consumer Staples | 11.07% |
| 5 | Communication Services | 8.64% |
Similar funds
KCM
AG
AIC
PCA
HIC
V
RVM
FFA
Fairfield, Bush & Co's Q2 2021 Portfolio in Review
As of Q2 2021, Fairfield, Bush & Co held 168 positions worth $368M, up 5% from $350M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Fairfield, Bush & Co withdrew a net $11.6M in Q2 2021, closing 23 positions and reducing 57 holdings. Its most notable exit was Biogen, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fairfield, Bush & Co opened a new position in Albemarle worth $628K.
- Fairfield, Bush & Co's largest Q2 2021 buy was Albemarle: 3,730 shares worth $628K.
- Fairfield, Bush & Co added most to iShares 1-3 Year Treasury Bond ETF in Q2 2021, an estimated $3.27M increase.
- Fairfield, Bush & Co's biggest Q2 2021 reduction was Apple, cutting an estimated $1.91M.
- Fairfield, Bush & Co fully exited Biogen in Q2 2021, selling an estimated $1.96M.
- Fairfield, Bush & Co's ten largest holdings make up 40% of its $368M portfolio in Q2 2021.
- Fairfield, Bush & Co opened 6 new positions and closed 23 in Q2 2021.
- Fairfield, Bush & Co's portfolio value rose 5% quarter-over-quarter to $368M.
Based on Fairfield, Bush & Co's 13F filing for Q2 2021, filed 2 Aug 2021.